Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Raising the Dose and Raising the Cost: The Case of Pembrolizumab in Lung Cancer

academic.oup.comJuly 24, 2017

Tag: pembrolizumab , lung cancer

PharmaSources Customer Service